Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer.

Saved in:
Bibliographic Details
Title: Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer.
Authors: Rojas, Luis1,2 (AUTHOR), Muñiz, Sabrina3 (AUTHOR), Medina, Lidia4 (AUTHOR), Peña, Jose5 (AUTHOR), Acevedo, Francisco5 (AUTHOR), Pinto, Mauricio P.5 (AUTHOR), Sanchez, Cesar5 (AUTHOR) csanchez@med.puc.cl
Source: PLoS ONE. 2/5/2020, Vol. 15 Issue 2, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0227961